Here's how Moderna's IPO stacks up against others in biotech
December 06, 2018 at 06:24 AM EST
Cambridge biotech Moderna Therapeutics' announcement that it would seek up to $600 million in its IPO raised eyebrows. But it's just be the latest in the biotech industry's increasingly high-priced market launches.
